no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acetylation in hormone signaling and the cell cycle
|
Fu, Maofu |
|
2002 |
71-72 |
3 |
p. 259-276 18 p. |
article |
2 |
A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system
|
Comerford, Iain |
|
2013 |
71-72 |
3 |
p. 269-283 15 p. |
article |
3 |
Angiogenesis, adipokines and breast cancer
|
Vona-Davis, Linda |
|
2009 |
71-72 |
3 |
p. 193-201 9 p. |
article |
4 |
Angiogenic factors in bone local environment
|
Chim, Shek Man |
|
2013 |
71-72 |
3 |
p. 297-310 14 p. |
article |
5 |
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance
|
Rusnati, Marco |
|
2015 |
71-72 |
3 |
p. 293-310 18 p. |
article |
6 |
Application of bone morphogenetic proteins in spinal fusion
|
Gupta, Munish C. |
|
2005 |
71-72 |
3 |
p. 347-355 9 p. |
article |
7 |
A (selective) history of Australian involvement in cytokine biology
|
Nicola, Nicos A. |
|
2013 |
71-72 |
3 |
p. 179-187 9 p. |
article |
8 |
BMP antagonists: Their roles in development and involvement in pathophysiology
|
Yanagita, Motoko |
|
2005 |
71-72 |
3 |
p. 309-317 9 p. |
article |
9 |
BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk
|
Miyazono, Kohei |
|
2005 |
71-72 |
3 |
p. 251-263 13 p. |
article |
10 |
BMPs: From bone morphogenetic proteins to body morphogenetic proteins
|
Reddi, A.H. |
|
2005 |
71-72 |
3 |
p. 249-250 2 p. |
article |
11 |
BMP signaling and early embryonic patterning
|
Kishigami, Satoshi |
|
2005 |
71-72 |
3 |
p. 265-278 14 p. |
article |
12 |
Bone Morphogenetic Protein signaling in joint homeostasis and disease
|
Lories, Rik J.U. |
|
2005 |
71-72 |
3 |
p. 287-298 12 p. |
article |
13 |
Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: Experimental studies in the non-human primate Papio ursinus
|
Ripamonti, Ugo |
|
2005 |
71-72 |
3 |
p. 357-368 12 p. |
article |
14 |
Bone morphogenetic proteins in dentin regeneration for potential use in endodontic therapy
|
Nakashima, Misako |
|
2005 |
71-72 |
3 |
p. 369-376 8 p. |
article |
15 |
Bone morphogenetic proteins in development and homeostasis of kidney
|
Simic, Petra |
|
2005 |
71-72 |
3 |
p. 299-308 10 p. |
article |
16 |
Can cord blood cells support the cytokine storm in GvHD?
|
Cohen, Shara B.A |
|
2000 |
71-72 |
3 |
p. 185-197 13 p. |
article |
17 |
Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
|
Senta, H. |
|
2009 |
71-72 |
3 |
p. 213-222 10 p. |
article |
18 |
Conference Calendar
|
|
|
2002 |
71-72 |
3 |
p. 295-296 2 p. |
article |
19 |
Conference Calendar
|
|
|
2005 |
71-72 |
3 |
p. V-VI nvt p. |
article |
20 |
Conference calendar
|
|
|
1996 |
71-72 |
3 |
p. 294- 1 p. |
article |
21 |
Conference calendar
|
|
|
1997 |
71-72 |
3 |
p. 237-238 2 p. |
article |
22 |
Conference calendar
|
|
|
2006 |
71-72 |
3 |
p. V- 1 p. |
article |
23 |
Connective tissue growth factor: a mediator of TGF-β action on fibroblasts
|
Grotendorst, Gary R. |
|
1997 |
71-72 |
3 |
p. 171-179 9 p. |
article |
24 |
Considering TWEAK as a target for therapy in renal and vascular injury
|
Ortiz, Alberto |
|
2009 |
71-72 |
3 |
p. 251-258 8 p. |
article |
25 |
Control of the G1 phase cyclin-dependent kinases by mitogenic growth factors and the extracellular matrix
|
Assoian, Richard K. |
|
1997 |
71-72 |
3 |
p. 165-170 6 p. |
article |
26 |
CXCL16 in kidney and cardiovascular injury
|
Izquierdo, María Concepción |
|
2014 |
71-72 |
3 |
p. 317-325 9 p. |
article |
27 |
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
|
Liu, Mingli |
|
2011 |
71-72 |
3 |
p. 121-130 10 p. |
article |
28 |
CXCR3 ligands in disease and therapy
|
Van Raemdonck, Katrien |
|
2015 |
71-72 |
3 |
p. 311-327 17 p. |
article |
29 |
Cytokine regulation during the formation of the fetal–maternal interface: Focus on cell–cell adhesion and remodelling of the extra-cellular matrix
|
McEwan, Miranda |
|
2009 |
71-72 |
3 |
p. 241-249 9 p. |
article |
30 |
Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia
|
Cocco, Claudia |
|
2011 |
71-72 |
3 |
p. 149-156 8 p. |
article |
31 |
Cytokines in head and neck cancer
|
Pries, Ralph |
|
2006 |
71-72 |
3 |
p. 141-146 6 p. |
article |
32 |
Cytokines revisited at Hilton Head
|
Richmond, Ann |
|
2000 |
71-72 |
3 |
p. 255-266 12 p. |
article |
33 |
Dangerous liaisons between interleukin-6 cytokine and toll-like receptor families: A potent combination in inflammation and cancer
|
Mansell, Ashley |
|
2013 |
71-72 |
3 |
p. 249-256 8 p. |
article |
34 |
Defensins: “Simple” antimicrobial peptides or broad-spectrum molecules?
|
Suarez-Carmona, Meggy |
|
2015 |
71-72 |
3 |
p. 361-370 10 p. |
article |
35 |
Delivery of bone morphogenetic proteins for orthopedic tissue regeneration
|
Seeherman, Howard |
|
2005 |
71-72 |
3 |
p. 329-345 17 p. |
article |
36 |
Editorial Board
|
|
|
2009 |
71-72 |
3 |
p. CO2- 1 p. |
article |
37 |
Editorial Board
|
|
|
2013 |
71-72 |
3 |
p. CO2- 1 p. |
article |
38 |
Editorial Board
|
|
|
2011 |
71-72 |
3 |
p. CO2- 1 p. |
article |
39 |
Editorial Board
|
|
|
2012 |
71-72 |
3 |
p. CO2- 1 p. |
article |
40 |
Editorial Board and Publication information
|
|
|
2006 |
71-72 |
3 |
p. CO2- 1 p. |
article |
41 |
Editorial Board and Publication information
|
|
|
2015 |
71-72 |
3 |
p. IFC- 1 p. |
article |
42 |
Editorial Board and Publication information
|
|
|
2014 |
71-72 |
3 |
p. IFC- 1 p. |
article |
43 |
Editorial Board/ Publication Info
|
|
|
2005 |
71-72 |
3 |
p. CO2- 1 p. |
article |
44 |
Emerging role of bone morphogenetic proteins in angiogenesis
|
David, Laurent |
|
2009 |
71-72 |
3 |
p. 203-212 10 p. |
article |
45 |
Emerging roles for TNIP1 in regulating post-receptor signaling
|
Ramirez, Vincent P. |
|
2012 |
71-72 |
3 |
p. 109-118 10 p. |
article |
46 |
Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability
|
Fowlkes, John L. |
|
2002 |
71-72 |
3 |
p. 277-287 11 p. |
article |
47 |
Facts and Faces
|
|
|
2002 |
71-72 |
3 |
p. 291-294 4 p. |
article |
48 |
Facts and faces
|
|
|
1996 |
71-72 |
3 |
p. 289-293 5 p. |
article |
49 |
Facts and faces
|
|
|
1997 |
71-72 |
3 |
p. 233-235 3 p. |
article |
50 |
Fine tuning type I interferon responses
|
Hertzog, Paul J. |
|
2013 |
71-72 |
3 |
p. 217-225 9 p. |
article |
51 |
Focus on TNF
|
|
|
1996 |
71-72 |
3 |
p. 209- 1 p. |
article |
52 |
Growth factors in skeletal muscle regeneration
|
Husmann, Irene |
|
1996 |
71-72 |
3 |
p. 249-258 10 p. |
article |
53 |
Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders
|
Brisse, Ellen |
|
2015 |
71-72 |
3 |
p. 263-280 18 p. |
article |
54 |
High-mobility group box 1 (HMGB1) protein: Friend and foe
|
Ulloa, Luis |
|
2006 |
71-72 |
3 |
p. 189-201 13 p. |
article |
55 |
IGFBP-2: The dark horse in metabolism and cancer
|
Russo, V.C. |
|
2015 |
71-72 |
3 |
p. 329-346 18 p. |
article |
56 |
IGF2 signaling and regulation in cancer
|
Brouwer-Visser, Jurriaan |
|
2015 |
71-72 |
3 |
p. 371-377 7 p. |
article |
57 |
Implications of cytokine gene polymorphisms on the orchestration of the immune response: Lessons learned from oral diseases
|
Dutra, Walderez O. |
|
2009 |
71-72 |
3 |
p. 223-232 10 p. |
article |
58 |
Insensitivity to the growth inhibitory effects of activin A: An acquired capability in prostate cancer progression
|
Ottley, Edward |
|
2012 |
71-72 |
3 |
p. 119-125 7 p. |
article |
59 |
Integration of lectin–glycan recognition systems and immune cell networks in CNS inflammation
|
Mendez-Huergo, Santiago P. |
|
2014 |
71-72 |
3 |
p. 247-255 9 p. |
article |
60 |
Interactions between opioid and chemokine receptors: heterologous desensitization
|
Steele, Amber D. |
|
2002 |
71-72 |
3 |
p. 209-222 14 p. |
article |
61 |
Interferons in 1999
|
Pfeffer, Lawrence M. |
|
2000 |
71-72 |
3 |
p. 251-254 4 p. |
article |
62 |
Interleukin-6, its role in fibrosing conditions
|
O’Reilly, Steven |
|
2012 |
71-72 |
3 |
p. 99-107 9 p. |
article |
63 |
Intracellular trafficking and secretion of inflammatory cytokines
|
Stow, Jennifer L. |
|
2013 |
71-72 |
3 |
p. 227-239 13 p. |
article |
64 |
Letter to the editor on “Demoulin JB, Essaghir A. PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev (2014)”
|
Keasey, M.P. |
|
2014 |
71-72 |
3 |
p. 245- 1 p. |
article |
65 |
LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells
|
Borges, Luis |
|
2000 |
71-72 |
3 |
p. 209-217 9 p. |
article |
66 |
Neurotrophic factors for the treatment of Parkinson's disease
|
Sullivan, Aideen M. |
|
2011 |
71-72 |
3 |
p. 157-165 9 p. |
article |
67 |
On the TRAIL to apoptosis
|
Baetu, Tudor M |
|
2002 |
71-72 |
3 |
p. 199-207 9 p. |
article |
68 |
Overview of cytokine and growth factor review focus on Australia
|
Hertzog, Paul J. |
|
2013 |
71-72 |
3 |
p. 175-177 3 p. |
article |
69 |
PDGF receptor signaling networks in normal and cancer cells
|
Demoulin, Jean-Baptiste |
|
2014 |
71-72 |
3 |
p. 273-283 11 p. |
article |
70 |
Plasticity and cross-talk of Interleukin 6-type cytokines
|
Garbers, Christoph |
|
2012 |
71-72 |
3 |
p. 85-97 13 p. |
article |
71 |
Recent advances in TGF-β effects on chondrocyte metabolism
|
Grimaud, Eva |
|
2002 |
71-72 |
3 |
p. 241-257 17 p. |
article |
72 |
Recent development in pleiotropic effects of statins on cardiovascular disease through regulation of transforming growth factor-beta superfamily
|
Ma, Sze |
|
2011 |
71-72 |
3 |
p. 167-175 9 p. |
article |
73 |
Regulation and dysregulation of tumor necrosis factor receptor-1
|
Puimège, Leen |
|
2014 |
71-72 |
3 |
p. 285-300 16 p. |
article |
74 |
Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): A rose by any other name…
|
Li, Li |
|
2006 |
71-72 |
3 |
p. 203-216 14 p. |
article |
75 |
Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor
|
McCaffery, Peter |
|
2000 |
71-72 |
3 |
p. 233-249 17 p. |
article |
76 |
Role of microRNA-155 in autoimmunity
|
Leng, Rui-Xue |
|
2011 |
71-72 |
3 |
p. 141-147 7 p. |
article |
77 |
Role of Oncostatin M in hematopoiesis and liver development
|
Miyajima, Atsushi |
|
2000 |
71-72 |
3 |
p. 177-183 7 p. |
article |
78 |
Roles of activin in tissue repair, fibrosis, and inflammatory disease
|
Werner, Sabine |
|
2006 |
71-72 |
3 |
p. 157-171 15 p. |
article |
79 |
Sensing and responding to cytosolic viruses invasions: An orchestra of kaleidoscopic ubiquitinations
|
Liu, Xing |
|
2015 |
71-72 |
3 |
p. 379-387 9 p. |
article |
80 |
Signaling mechanisms, interaction partners, and target genes of STAT6
|
Hebenstreit, Daniel |
|
2006 |
71-72 |
3 |
p. 173-188 16 p. |
article |
81 |
Signalling by the βc family of cytokines
|
Hercus, Timothy R. |
|
2013 |
71-72 |
3 |
p. 189-201 13 p. |
article |
82 |
SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer
|
Li, Yi |
|
2012 |
71-72 |
3 |
p. 127-138 12 p. |
article |
83 |
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
|
Bezooijen, Rutger L. van |
|
2005 |
71-72 |
3 |
p. 319-327 9 p. |
article |
84 |
STAT family of transcription factors in cytokine-mediated biological responses
|
Takeda, Kiyoshi |
|
2000 |
71-72 |
3 |
p. 199-207 9 p. |
article |
85 |
Suicide by order: Some open questions about the cell-killing activities of the TNF ligand and receptor families
|
Wallach, David |
|
1996 |
71-72 |
3 |
p. 211-221 11 p. |
article |
86 |
Suppression of cytokine signaling: The SOCS perspective
|
Linossi, Edmond M. |
|
2013 |
71-72 |
3 |
p. 241-248 8 p. |
article |
87 |
The activins and their binding protein, follistatin—Diagnostic and therapeutic targets in inflammatory disease and fibrosis
|
Hedger, M.P. |
|
2013 |
71-72 |
3 |
p. 285-295 11 p. |
article |
88 |
The angiopoietin/TIE receptor system: Focusing its role for ischemia-reperfusion injury
|
Hilbert, Tobias |
|
2015 |
71-72 |
3 |
p. 281-291 11 p. |
article |
89 |
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
|
Vincent, Fabien B. |
|
2013 |
71-72 |
3 |
p. 203-215 13 p. |
article |
90 |
The biology of Toll-like receptors
|
Means, Terry K. |
|
2000 |
71-72 |
3 |
p. 219-232 14 p. |
article |
91 |
The 9E3/CEF4 gene and its product the chicken chemotactic and angiogenic factor (cCAF): Potential roles in wound healing and tumor development
|
Martins-Green, M. |
|
1997 |
71-72 |
3 |
p. 221-232 12 p. |
article |
92 |
The emerging role of soluble HLA-G in the control of chemotaxis
|
Morandi, Fabio |
|
2014 |
71-72 |
3 |
p. 327-335 9 p. |
article |
93 |
The essential roles of TGFB1 in reproduction
|
Ingman, Wendy V. |
|
2009 |
71-72 |
3 |
p. 233-239 7 p. |
article |
94 |
The family of IL-10-related cytokines and their receptors: related, but to what extent?
|
Kotenko, Sergei V |
|
2002 |
71-72 |
3 |
p. 223-240 18 p. |
article |
95 |
The function of BAFF on T helper cells in autoimmunity
|
Chen, Maogen |
|
2014 |
71-72 |
3 |
p. 301-305 5 p. |
article |
96 |
The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): A novel, pleiotropic member of the C-X-C chemokine superfamily
|
Neville, Lewis F. |
|
1997 |
71-72 |
3 |
p. 207-219 13 p. |
article |
97 |
The immunology of Eta-1/osteopontin
|
Weber, Georg F |
|
1996 |
71-72 |
3 |
p. 241-248 8 p. |
article |
98 |
The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor
|
Pestka, Sidney |
|
1997 |
71-72 |
3 |
p. 189-206 18 p. |
article |
99 |
The potential biological and clinical significance of the soluble tumor necrosis factor receptors
|
Aderka, Dan |
|
1996 |
71-72 |
3 |
p. 231-240 10 p. |
article |
100 |
The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers
|
Freitas, Christelle |
|
2014 |
71-72 |
3 |
p. 307-316 10 p. |
article |
101 |
The role of bone morphogenetic proteins in endochondral bone formation
|
Tsumaki, Noriyuki |
|
2005 |
71-72 |
3 |
p. 279-285 7 p. |
article |
102 |
The role of bone morphogenetic proteins in myeloma cell survival
|
Holien, Toril |
|
2014 |
71-72 |
3 |
p. 343-350 8 p. |
article |
103 |
The role of cytokines in cancer
|
Oppenheim, Joost |
|
1996 |
71-72 |
3 |
p. 279-288 10 p. |
article |
104 |
The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy
|
Hills, Claire E. |
|
2011 |
71-72 |
3 |
p. 131-139 9 p. |
article |
105 |
The role of the IL-22/IL-22R1 axis in cancer
|
Lim, Chrissie |
|
2014 |
71-72 |
3 |
p. 257-271 15 p. |
article |
106 |
The sterile immune response during hepatic ischemia/reperfusion
|
van Golen, Rowan F. |
|
2012 |
71-72 |
3 |
p. 69-84 16 p. |
article |
107 |
The unbearable lightness of bone marrow homeostasis
|
Agas, Dimitrios |
|
2015 |
71-72 |
3 |
p. 347-359 13 p. |
article |
108 |
TNF and pregnancy: the paradigm of a complex interaction
|
Argilés, Josep M. |
|
1997 |
71-72 |
3 |
p. 181-188 8 p. |
article |
109 |
Transcriptional anti-angiogenesis therapy of human pancreatic cancer
|
Xie, Keping |
|
2006 |
71-72 |
3 |
p. 147-156 10 p. |
article |
110 |
Tumor necrosis factors in 1996
|
Pfizenmaier, Klaus |
|
1996 |
71-72 |
3 |
p. 271-277 7 p. |
article |
111 |
Tumour necrosis factors in immune regulation: Everything that's interesting is … New!
|
Pasparakis, Manolis |
|
1996 |
71-72 |
3 |
p. 223-229 7 p. |
article |
112 |
Type I interferon in neurological disease—The devil from within
|
Hofer, Markus J. |
|
2013 |
71-72 |
3 |
p. 257-267 11 p. |
article |
113 |
Vascular endothelial growth factor and its receptors
|
Klagsbrun, Michael |
|
1996 |
71-72 |
3 |
p. 259-270 12 p. |
article |
114 |
Who climbs the tryptophan ladder? On the structure and function of the WSXWS motif in cytokine receptors and thrombospondin repeats
|
Olsen, Johan G. |
|
2014 |
71-72 |
3 |
p. 337-341 5 p. |
article |
115 |
Withdrawal of “The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction” [Cytokine & Growth Factor Reviews 12(1) (2001) 41–51]
|
Schlegel, Amnon |
|
2002 |
71-72 |
3 |
p. 289- 1 p. |
article |